Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Roche Notches Big IO Win With Tecentriq/Avastin Combo In First-Line HCC

Mon, 10/21/2019 - 12:12pm

Following quickly on a Bristol trial failure with Opdivo in first-line HCC, Roche’s PD-L1 inhibitor looks poised to be the...

      Related Stories 

J&J's Spravato Set For EU Launches Soon

Mon, 10/21/2019 - 8:24am

If the nasal spray is approved by the European Commission, seven months after getting the green light in the US...

      Related Stories 

Pipeline Watch: Phase III Readouts For Bimekizumab, RHB-104

Mon, 10/21/2019 - 2:01am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Roche Expects Better Xofluza Sales After New Indication

Fri, 10/18/2019 - 3:27pm

Flu treatment is newly approved for patients at higher risk of flu complications, and Roche is studying other patient groups...

      Related Stories 

Tech Transfer Roundup: Trio Of Deals Bolster Spherix’s Cancer Strategy

Fri, 10/18/2019 - 1:37pm

The New York biotech announces option deals with two universities, asset license from CBM BioPharma. Bayer inks research collaborations with...

      Related Stories 

Evenity Gets CHMP Nod On Second Pass

Fri, 10/18/2019 - 9:12am

UCB and Amgen’s osteoporosis drug Evenity has been given a positive opinion in Europe after initial rejection. But cardiovascular safety...

      Related Stories 

Sofinnova Raises €333m For European Biotech Fund

Fri, 10/18/2019 - 8:08am

Global investors back Paris-headquartered Sofinnova to recoup investment in life science start-ups.

      Related Stories 

Kiadis Crushed By EMA Rejection Of T-Cell Therapy

Fri, 10/18/2019 - 6:55am

The Dutch company's dataset on its stem cell transplant adjunct ATIR101 is not enough to satisfy European regulators as the...

      Related Stories 

Novartis Q3 Preview: Zolgensma Back In The Spotlight

Thu, 10/17/2019 - 11:51pm

Analysts will be keen to hear about the launches of key new drugs Zolgensma and Mayzent as they ponder how...

      Related Stories 

Need For Partnering Won’t Change But Shape Might - BioJapan

Thu, 10/17/2019 - 6:46pm

While industry participants at BioJapan expect big pharma to continue to seek external partnerships and acquisitions to bolster pipelines, the...

      Related Stories 

Teva's Opioid Options Come Into More Focus Ahead Of Third Quarter Financials

Thu, 10/17/2019 - 4:35pm

Investors may have more clarity on Teva's long-term outlook if the generic drug maker reaches a settlement in a big...

      Related Stories 

Genfit Thinks Intercept’s Lead In NASH Not As Wide As Perceived

Thu, 10/17/2019 - 2:01pm

Genfit believes elafibranor’s clean tolerability and safety profile may help narrow the gap between it and Intercept’s OCA, with safety...

      Related Stories 

AstraZeneca Q3 Preview: Oncology Portfolio Keeps Growing

Thu, 10/17/2019 - 6:55am

AstraZeneca, which analysts said had an 'exceptional' second quarter, is expected to have also kept that momentum up in the...

      Related Stories 

Lilly’s Pegilodecakin Fails Pancreatic Cancer Test

Thu, 10/17/2019 - 3:46am

The company's immunotherapy failed to improve survival of pancreatic patients compared to chemotherapy. Lilly will be hoping pegilodecakin has more...

      Related Stories 

Dainippon’s Cynata Quest Falls Through As Sides Remain Apart

Wed, 10/16/2019 - 9:07pm

Japanese firm backs off potential acquisition of Australian cell therapy venture after the two sides fail to agree on deal...

      Related Stories